Q: Cohbar had a big day on Friday.Your observations appreciated.
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: Hello
I have a position in CRH that is about flat from where I bought it. Do you think it is worth switching from CRH to COV?
Thanks
Amy
I have a position in CRH that is about flat from where I bought it. Do you think it is worth switching from CRH to COV?
Thanks
Amy
Q: I bought COV on the sharp rise, 25% of full position (yes I am down a little). Is it a good time to top up with all the recent news and the small drop?
Q: Good morning from the West Coast. What is your opinion of ATRS as a long term hold in a growth portfolio?
Thanks
Rick
Thanks
Rick
Q: are you aware of any news that would result in a $7 drop (over 5%) in price?
ed in montreal
ed in montreal
Q: Dear Gentlemen.
I want to add 2%+ on my healthcare sector. I Have GUD 1.5% &IBB 1.5% for at least 5 years. To complete the sector which stock or ETF (C$ or U$) to add to the sector
Thank you.
Best regards
I want to add 2%+ on my healthcare sector. I Have GUD 1.5% &IBB 1.5% for at least 5 years. To complete the sector which stock or ETF (C$ or U$) to add to the sector
Thank you.
Best regards
Q: Is this can be a speculative "buy" or still can go down or worth nothing.
Thanks
Thanks
Q: Hi,
Just curious. Prometic float display a number of shares of 683 781 000 which means that any 1 dollar tick will increase the value of the company by $ 683 781 000.
I show assets of 62M and liabilities of 121M
I show revenues of 4M.
I know that you will answer discounted cash flow and phase 3 trials. but in this new world of ...." I don't care about valuations type of thinking" would it make sense to really ask how high the stock value will go.
CDJ
Just curious. Prometic float display a number of shares of 683 781 000 which means that any 1 dollar tick will increase the value of the company by $ 683 781 000.
I show assets of 62M and liabilities of 121M
I show revenues of 4M.
I know that you will answer discounted cash flow and phase 3 trials. but in this new world of ...." I don't care about valuations type of thinking" would it make sense to really ask how high the stock value will go.
CDJ
Q: Any opinion on this American health-care stock?? I own some and have doubts about holding it.Thinking about averaging down on Savaria Thanks Jim
Q: Just need a bit of clarification about your response to my biotech questions answered earlier today. You begin by stating that once biotech has a run, it usually continues running. However, subsequently, you call it a 'tough sector'. Does this mean you are lukewarm to the sector?
Thx
Karim
Thx
Karim
Q: Hi,
What do you think about Zymeworks Inc. (ZYME)?
Thanks,
Gord
What do you think about Zymeworks Inc. (ZYME)?
Thanks,
Gord
Q: Can I get your opinion of the latest quarter and the out look for this company. Thanks
Q: Can you explain the recent run up in price?
Q: My biotech holdings include Celegene at 3% and alexion at 1.5%. I am looking to obtain a basket of these stocks, the best in your opinion, as opposed to getting the sector etf.
My question are as follows:
1. Do you feel now is an opportune time to be adding to biotech, or has the sector run up too far?
2. If the time is right, what would be your top complementary picks to my current positions ( mid cap to large cap) and how many should I hold? Please advise what an adequate overall portfolio position would be for the sector, for an investor with a palate for moderate risk and a long way term view.
Thank you for your counsel,
Karim .
My question are as follows:
1. Do you feel now is an opportune time to be adding to biotech, or has the sector run up too far?
2. If the time is right, what would be your top complementary picks to my current positions ( mid cap to large cap) and how many should I hold? Please advise what an adequate overall portfolio position would be for the sector, for an investor with a palate for moderate risk and a long way term view.
Thank you for your counsel,
Karim .
Q: Just wondered what you thought of frx
Q: how serious is the whistleblower suit to Gilead at this time?
Q: Are there any Canadian or US Health Care ETF's preferably hedged I could use in my RIF? I currently hold HHL at a 6% weighting.
Dick
Dick
Q: I have a full position in JAZZ PHARMACEUTICALS PLC (JAZZ:NSQ, US).
Is this company a hold in your opinion? Or should one cut and run?
Thanks
Is this company a hold in your opinion? Or should one cut and run?
Thanks
Q: 3:05 PM 9/27/2017
I have been looking at Extendicare as a source of slow growth and a good dividend, but I have a number of questions about the company that you may be able to answer.
1. What happened in May 2013 when the company cut the monthly dividend from 7 cents to 4 cents? In the same year Revenue dropped from $2,037 million in 2012 to $784 million in 2013 and Operating Income was cut in half.
2. Morningstar shows Equity of $135 million and Debt of $533 million. Can you explain these figures as they relate to Market Cap of $823 million?
3. What is the actual current $ debt, and Debt/Cashflow, and is it unacceptably high?
4. What do you think of management and do you forsee any problems ahead for the company other than inflation and minimum wage increases.
5. Do you have any concerns about the company's ability to continue paying the 4 cent a month 5.2% dividend?
6. INK insider shows that there has been good net insider buying in the last year at EXE with the CEO almost doubling his holding to 240,000 shares with rights to an additionsl 197,000+ shares. In contrast I note that Directors at Sienna have sold nearly 200,000 shares of SIA in the last year. Does this hint at trouble at Sienna and better days ahead for Extendicare?
7. Would you consider EXE's dividend any more or less reliable that those of SIA or CSH.UN? I currently have a 1% position in EXE.
8. Would adding new Money to my 1% position in EXE for the dividend, be a complement to my positions in SIA [4%] and in CSH.UN [3%]?
Thank you very much............ Paul K.
I have been looking at Extendicare as a source of slow growth and a good dividend, but I have a number of questions about the company that you may be able to answer.
1. What happened in May 2013 when the company cut the monthly dividend from 7 cents to 4 cents? In the same year Revenue dropped from $2,037 million in 2012 to $784 million in 2013 and Operating Income was cut in half.
2. Morningstar shows Equity of $135 million and Debt of $533 million. Can you explain these figures as they relate to Market Cap of $823 million?
3. What is the actual current $ debt, and Debt/Cashflow, and is it unacceptably high?
4. What do you think of management and do you forsee any problems ahead for the company other than inflation and minimum wage increases.
5. Do you have any concerns about the company's ability to continue paying the 4 cent a month 5.2% dividend?
6. INK insider shows that there has been good net insider buying in the last year at EXE with the CEO almost doubling his holding to 240,000 shares with rights to an additionsl 197,000+ shares. In contrast I note that Directors at Sienna have sold nearly 200,000 shares of SIA in the last year. Does this hint at trouble at Sienna and better days ahead for Extendicare?
7. Would you consider EXE's dividend any more or less reliable that those of SIA or CSH.UN? I currently have a 1% position in EXE.
8. Would adding new Money to my 1% position in EXE for the dividend, be a complement to my positions in SIA [4%] and in CSH.UN [3%]?
Thank you very much............ Paul K.
Q: Do you think we are at or close to the bottom? Would buying now put me in a position to have a substantial gain in 2 years lets say? Thanks